CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Total	Class A Common Stock	Class V Common Stock	Members' Equity	Common Stock Class A Common Stock	Common Stock Class V Common Stock	Retained Earnings / (Accumulated Deficit)	Accumulated Other Comprehensive Income (Loss)	Total Stockholders' Equity (Deficit) Attributable to biote Corp.	Non Controlling Interest
Beginning balance, units at Dec. 31, 2020				982,800
Beginning balance at Dec. 31, 2020	$ (17,075,000)						$ (17,052,000)	$ (23,000)	$ (17,075,000)
Distributions	(11,402,000)						(11,402,000)		(11,402,000)
Net income (loss)	32,619,000						32,619,000		32,619,000
Other comprehensive income (loss)	(17,000)							(17,000)	(17,000)
Ending balance, units at Dec. 31, 2021				982,800
Ending balance at Dec. 31, 2021	4,125,000						4,165,000	(40,000)	4,125,000
Net income (loss)	9,143,000						9,143,000		9,143,000
Other comprehensive income (loss)	1,000							1,000	1,000
Beginning balance, units at Dec. 31, 2021				982,800
Beginning balance at Dec. 31, 2021	4,125,000						4,165,000	(40,000)	4,125,000
Distributions	(12,886,000)						(9,575,000)		(9,575,000)	$ (3,311,000)
Net income (loss)	1,324,000
Business Combination: Capitalized transaction costs	(12,282,000)						(12,282,000)		(12,282,000)
Share-based compensation	0
Share-based compensation	82,180,000						82,180,000		82,180,000
Settlement of phantom equity rights	(7,250,000)						(7,250,000)		(7,250,000)
Vesting of RSUs	(424,000)						(424,000)		(424,000)
Vesting of RSUs, shares					1,950,557
Issuance of shares under SEPA	561,000						561,000		561,000
Issuance of shares under SEPA, shares			48,565,824		130,559
Ending balance at Dec. 31, 2022	(58,274,000)				$ 1,000	$ 5,000	(44,460,000)	(5,000)	(44,459,000)	(13,815,000)
Ending balance, shares at Dec. 31, 2022					9,655,387	48,565,824
Business Combination: Reverse recapitalization on May 26, 2022, units				(982,800)
Business Combination: Reverse recapitalization on May 26, 2022	(113,622,000)	$ 1,000	$ 5,000				(113,628,000)		(113,622,000)
Business Combination: Reverse recapitalization on May 26, 2022, shares		7,574,271	48,565,824
Business Combination: Noncontrolling interest on May 26, 2022							3,619,000	34,000	3,653,000	(3,653,000)
Net income (loss)	(7,819,000)						(969,000)		(969,000)	(6,850,000)
Other comprehensive income (loss)	1,000									(1,000)
Ending balance at Dec. 31, 2022	$ (58,274,000)				$ 1,000	$ 5,000	$ (44,460,000)	$ (5,000)	$ (44,459,000)	$ (13,815,000)
Ending balance, shares at Dec. 31, 2022					9,655,387	48,565,824